SLCO1B3 and cancer: Furthermore, we were able to detect Ct-SLCO1B3 mRNA levels in late stages of head and neck SCC tissue arising in the normal population (Figure S4B), suggesting that this could be an additional cancer that could be targeted by RTM44.